Shanghai, China

Tao Meng

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2025

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: The Innovative Contributions of Tao Meng

Introduction

Tao Meng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies for cancer treatment. With a total of 9 patents to his name, his work has garnered attention for its potential impact on medical science.

Latest Patents

Among his latest patents is a tissue factor-targeted antibody-drug conjugate (ADC). This innovative ADC is designed to bind to the tissue factor (TF) antigen with high specificity. It boasts high affinity, low immunogenicity, and significant anti-tumor activity, making it a promising candidate for cancer therapies. Another notable patent involves an AXL-targeting antibody and its corresponding antibody-drug conjugate. This invention includes a method for preparing the antibody and ADC, which can effectively bind to purified human AXL protein and multiple AXL proteins on tumor cell surfaces. The AXL antibody-drug conjugate demonstrates remarkable performance against tumors with high AXL expression.

Career Highlights

Tao Meng has held positions at prestigious institutions such as the Chinese Academy of Sciences and Fudan University. His work at these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in his field.

Collaborations

Throughout his career, Tao has worked alongside notable colleagues, including Jingkang Shen and Lanping Ma. These collaborations have further enriched his research and development efforts.

Conclusion

Tao Meng's innovative work in the field of biotechnology, particularly in targeted cancer therapies, showcases his dedication to advancing medical science. His numerous patents reflect his commitment to finding effective solutions for complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…